PMC:7076992 / 550-2072
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T9 | 396-404 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T10 | 580-588 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 1086-1095 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T12 | 1247-1251 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 138-145 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focuses |
| T3 | 896-899 | http://purl.obolibrary.org/obo/CLO_0050884 | denotes | ten |
| T4 | 934-937 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T5 | 1033-1036 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T6 | 1140-1150 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 42-57 | Chemical | denotes | anti-viral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T2 | 53-57 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T3 | 282-297 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T4 | 344-354 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T5 | 673-690 | Chemical | denotes | anti-viral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T6 | 702-713 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T7 | 741-752 | Chemical | denotes | ganciclovir | http://purl.obolibrary.org/obo/CHEBI_465284 |
| T8 | 792-811 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T9 | 792-801 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T10 | 802-811 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T11 | 1010-1021 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T12 | 1022-1031 | Chemical | denotes | phosphate | http://purl.obolibrary.org/obo/CHEBI_18367|http://purl.obolibrary.org/obo/CHEBI_26020|http://purl.obolibrary.org/obo/CHEBI_35780|http://purl.obolibrary.org/obo/CHEBI_43474 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T4 | 1086-1095 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 0-103 | Sentence | denotes | There is presently no vaccine or specific anti-viral drug regime used to treat critically ill patients. |
| T7 | 104-236 | Sentence | denotes | The management of patients mainly focuses on the provision of supportive care, e.g., oxygenation, ventilation, and fluid management. |
| T8 | 237-420 | Sentence | denotes | Combination treatment of low-dose systematic corticosteroids and anti-virals and atomization inhalation of interferon have been encouraged as part of critical COVID-19 management [2]. |
| T9 | 421-540 | Sentence | denotes | Other reported therapeutic agents that are used for the treatment of seriously ill patients have been noted in Table 1. |
| T10 | 541-588 | Sentence | denotes | Table 1 Potential treatment options of COVID-19 |
| T11 | 589-634 | Sentence | denotes | Classes Potential treatment options Reference |
| T12 | 635-845 | Sentence | denotes | Anti-viral > 85% of patients received anti-viral agents, including oseltamivir (75 mg every 12 h orally), ganciclovir (0.25 g every 12 h intravenously), and lopinavir/ritonavir tablets (400/100 mg twice daily). |
| T13 | 846-973 | Sentence | denotes | Remdesivir is currently under trials at more than ten medical institutions in Wuhan and has been known to prevent MERS-CoV. [1] |
| T14 | 974-1155 | Sentence | denotes | Anti-malarial An old anti-malarial, chloroquine phosphate, has been effective in inhibiting the exacerbation of pneumonia due to its anti-viral and anti-inflammatory activities. [3] |
| T15 | 1156-1305 | Sentence | denotes | Herbal treatments There was widespread use of Traditional Chinese Medicine during the last SARS-COV outbreak and it is currently being used in China. |
| T16 | 1306-1522 | Sentence | denotes | The five most commonly used herbs were Astragali Radix (Huangqi), Glycyrrhizae Radix Et Rhizoma (Gancao), Saposhnikoviae Radix (Fangfeng), Atractylodis Macrocephalae Rhizoma (Baizhu), and Lonicerae Japonicae Flo. [4] |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32178711-32070391-23646623 | 417-418 | 32070391 | denotes | 2 |
| 32178711-32081636-23646624 | 971-972 | 32081636 | denotes | 1 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 32 | 1247-1255 | Species | denotes | SARS-COV | Tax:694009 |
| 33 | 655-663 | Species | denotes | patients | Tax:9606 |
| 34 | 960-968 | Species | denotes | MERS-CoV | Tax:1335626 |
| 35 | 702-713 | Chemical | denotes | oseltamivir | MESH:D053139 |
| 36 | 741-752 | Chemical | denotes | ganciclovir | MESH:D015774 |
| 37 | 792-811 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 38 | 846-856 | Chemical | denotes | Remdesivir | MESH:C000606551 |
| 39 | 1010-1031 | Chemical | denotes | chloroquine phosphate | MESH:C023676 |
| 40 | 1086-1095 | Disease | denotes | pneumonia | MESH:D011014 |
| 41 | 1458-1479 | Disease | denotes | Macrocephalae Rhizoma | |
| 43 | 580-588 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 49 | 94-102 | Species | denotes | patients | Tax:9606 |
| 50 | 122-130 | Species | denotes | patients | Tax:9606 |
| 51 | 504-512 | Species | denotes | patients | Tax:9606 |
| 52 | 79-93 | Disease | denotes | critically ill | MESH:D016638 |
| 53 | 396-404 | Disease | denotes | COVID-19 | MESH:C000657245 |